SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-315712
Filing Date
2019-12-17
Accepted
2019-12-17 09:13:03
Documents
14
Period of Report
2019-12-17
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d851263d8k.htm   iXBRL 8-K 46172
2 EX-3.1 d851263dex31.htm EX-3.1 25311
3 EX-3.2 d851263dex32.htm EX-3.2 41858
  Complete submission text file 0001193125-19-315712.txt   265959

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA once-20191217.xsd EX-101.SCH 3042
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE once-20191217_lab.xml EX-101.LAB 19652
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE once-20191217_pre.xml EX-101.PRE 12288
14 EXTRACTED XBRL INSTANCE DOCUMENT d851263d8k_htm.xml XML 3568
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36819 | Film No.: 191288685
SIC: 2836 Biological Products, (No Diagnostic Substances)